PDCD1 and neoplasm: Mice treated with PD1 ARMed EGFRvIII CAR T cells exhibited a significant reduction in tumor BLI compared with both UTD cells and CAR T cells alone (p = 0.00017 by multiple Mann-Whitney tests; Figure 5F).